CD4 and renal carcinoma: It was found that activated memory CD4 T cells and resting mast cells were significantly associated with the prognosis of renal cancer patients (HR = 9.4e + 05, p = 0.004 and HR = 3.7e – 03, p = 0.034, respectively).